<Disease><Name>SQUALENE SYNTHASE DEFICIENCY</Name><Synonym>NEURODEVELOPMENTAL DISORDER WITH LOW CHOLESTEROL AND ABNORMAL URINE ORGANIC ACIDS</Synonym><OMIM><Number>618156</Number><URL>http://omim.org/entry/618156</URL></OMIM><Orphanet><Number /><URL /></Orphanet><Protein><Number>Squalene synthase</Number><URL>https://www.uniprot.org/uniprot/P37268</URL></Protein><ExPASy><Number>2.5.1.21</Number><URL>http://enzyme.expasy.org/EC/2.5.1.21</URL></ExPASy><Gene /><ICD /><Summary>very rare;autosomal recessive;mutations in the FDFT1 gene;2-3 syndactyly of the toes, and facial dysmorphisms, resembling Smith-Lemli-Opitz syndrome [Coman D 2018, 2020]</Summary><Symptoms><symtomp><id>1956</id><symptom>behavior, autism or autistic-like / behaviour, autism or autistic-like</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2211</id><symptom>blindness, visual loss, visual impairment</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>3471</id><symptom>brain malformation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2221</id><symptom>cryptorchism</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>3819</id><symptom>developmental delay</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2227</id><symptom>dysmorphism / dysmorphic features</symptom><category>HEAD</category></symtomp><symtomp><id>2095</id><symptom>failure to thrive</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp><symtomp><id>3973</id><symptom>genital malformation</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>2449</id><symptom>heart involvement</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>2261</id><symptom>hyperreflexia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2631</id><symptom>hypersalivation</symptom><category>GENERAL TOPICS | HEAD</category></symtomp><symtomp><id>1740</id><symptom>hypoplasia of optic nerve or disk</symptom><category>EYES</category></symtomp><symtomp><id>2320</id><symptom>hypospadia</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>3826</id><symptom>intellectual disability/intellectual developmental disorder</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1951</id><symptom>irritability</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1998</id><symptom>liver involvement or dysfunction</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3863</id><symptom>low birthweight (small for gestational age)</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2012</id><symptom>photophobia or photosensitive defect in light-exposed area</symptom><category>SKIN</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2342</id><symptom>skeletal changes, skeletal abnormalities</symptom><category>SKELATAL DEFECT | SKELETAL DEFECT</category></symtomp><symtomp><id>3385</id><symptom>skin, abnormal</symptom><category>SKIN</category></symtomp><symtomp><id>2415</id><symptom>syndactyly / webbed toes</symptom><category>SKELETAL DEFECT | SKIN</category></symtomp><symtomp><id>3902</id><symptom>white matter changes, abnormalities</symptom><category>NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>1575</id><name>3-Methyladipic acid</name><specimen>urine</specimen><value>increased</value><min>1.10</min><max>7.20</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1663</id><name>2-Methylsuccinic acid</name><specimen>urine</specimen><value>increased</value><min>0.70</min><max>9.90</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>2116</id><name>Farnesol</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>0.12</max><unit>&#956;mol/l</unit><age /><method /><comment /></metabolite><metabolite><id>1668</id><name>1-Methylhydantoin</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>11.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1825</id><name>1-Methylhydantoin</name><specimen>urine</specimen><value>increased</value><min>49.00</min><max>370.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1099</id><name>Deoxycorticosterone</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1097</id><name>Deoxycorticosterone</name><specimen>plasma</specimen><value>increased</value><min>240.00</min><max>370.00</max><unit>pmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>1098</id><name>Deoxycorticosterone</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>pmol/l</unit><age /><method /><comment /></metabolite><metabolite><id>2005</id><name>3-Methyladipic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>1080</id><name>Cholestanol</name><specimen>plasma</specimen><value>decreased</value><min>    </min><max>    </max><unit>no data</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>295</id><name>Cholesterol</name><specimen>serum</specimen><value>decreased</value><min>3.60</min><max>8.00</max><unit>mmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>312</id><name>Cholesterol</name><specimen>serum</specimen><value>decreased</value><min>1.40</min><max>3.50</max><unit>mmol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>313</id><name>Cholesterol</name><specimen>serum</specimen><value>decreased</value><min>1.80</min><max>4.50</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>314</id><name>Cholesterol</name><specimen>serum</specimen><value>decreased</value><min>3.10</min><max>5.20</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1006</id><name>Cholesterol</name><specimen>serum</specimen><value>decreased</value><min>120.00</min><max>200.00</max><unit>mg/dl</unit><age>child</age><method /><comment /></metabolite><metabolite><id>105</id><name>2-Methylsuccinic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>3.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>619</id><name>2-Methylsuccinic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>6.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>620</id><name>2-Methylsuccinic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>9.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>623</id><name>2-Methylsuccinic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method /><comment /></metabolite><metabolite><id>2031</id><name>Mevalonolactone</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>111</id><name>Mevalonolactone</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>294</id><name>Triglycerides</name><specimen>serum</specimen><value>normal</value><min>40.00</min><max>128.00</max><unit>mg/dl</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>491</id><name>Triglycerides</name><specimen>serum</specimen><value>normal</value><min>30.00</min><max>99.00</max><unit>mg/dl</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1008</id><name>Triglycerides</name><specimen>various tissues</specimen><value>normal</value><min>    </min><max>    </max><unit>no data</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>7358</id><title>Squalene Synthase Deficiency</title><author>Coman D,</author><journal>Source  GeneReviews&#174; [Internet]</journal><year>2020</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>6217</id><title>Squalene Synthase Deficiency: Clinical, Biochemical, and Molecular Characterization of a Defect in Cholesterol Biosynthesis</title><author>Coman D,</author><journal>Am J Hum Genet</journal><year>2018</year><book /><volume>103</volume><number>1</number><pages>125-130</pages><co_aut>et al.</co_aut></literature><literature><id>6218</id><title>Squalene synthase deficiency; clinical, biochemical and molecular characterization of a novel defect in cholesterol biosynthesis</title><author /><journal>SSIEM 2018, Athens , Greece</journal><year>2018</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Coman D</co_aut></literature></Literatures></Disease>